Octagon Capital Advisors »

Perspective Therapeutics shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $19M 1.4M 13.35
2024-06-30 $16M 1.6M 9.97

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals (APLS)
Verona Pharma Sponsored Ads (VRNA)
Structure Therapeutics Sponsored Ads (GPCR)
Insmed Com Par $.01 Call Option (INSM)
Dianthus Therapeutics (DNTH)
Arrivent Biopharma (AVBP)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Nuvation Bio Com Cl A (NUVB)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Ocular Therapeutix (OCUL)
Miragen Therapeutics (VRDN)
Perspective Therapeutics Com New (CATX)
Mind Medicine Mindmed Com New (MNMD)
Cogent Biosciences (COGT)
Bridgebio Pharma (BBIO)

View all positions for Octagon Capital Advisors

Top funds holding Perspective Therapeutics

Henderson Group
BlackRock
BlackRock
Avidity Partners Management
Commodore Capital
Vanguard Group
Deerfield Management Company
Nicholson Wealth Management Group
Marshall Wace
Octagon Capital Advisors
Geode Capital Management
Hills Bank And Trust Company
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors

View all funds holding Perspective Therapeutics